FDA Import Refusal 799-2046163-2/10003/1 — Pfizer Canada
The FDA refused shipment 799-2046163-2/10003/1 from Pfizer Canada (Canada) on Dec 18, 2025. The refused product falls under Drugs and Biologics — APIXABAN (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 18, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61LCA44 APIXABAN (ANTI-COAGULANT)
- Charges
- 75